Searching for clues: Tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model

Journal of Infectious Diseases

Volumn 186, Issue , 2002, Pages S199-S208

  Mankowski, Joseph L ^a   Clements, Janice E ^a   Zink, M Christine ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOATTRACTANT; VIRUS RNA;

ANIMAL MODEL; ANIMAL TISSUE; BRAIN; CELL FUNCTION; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; MACACA; MICROGLIA; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENCEPHALITIS; VIRUS LOAD; VIRUS REPLICATION;

AIDS DEMENTIA COMPLEX; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; DISEASE MODELS, ANIMAL; HIV-1; HUMANS; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0036891424     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344938     Document Type: Article

References (55)

1. Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J. Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function. AIDS 1998; 12:F65-70.
2. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387:188-91.
3. Sacktor NC, Lyles RH, Skolasky RL, et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 1999; 52:1640-7.
4. Gray F, Scaravilli F, Everall I, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996;6:1-15.
5. Davis LE, Hjelle BL, Miller VE, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992;42:1736-9.
6. Murray EA, Rausch DM, Lendvay J, Sharer LR, Eiden LE. Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 1992;255:1246-9.
7. Gold LH, Fox HS, Henriksen SJ, et al. Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J Med Primatol 1998;27:104-12.
8. Sharer LR, Baskin GB, Cho ES, Murphey-Corb M, Blumberg BM, Epstein LG. Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host. Ann Neurol 1988;23(Suppl):S108-12.
9. Dickson DW, Belman AL, Park YD, et al. Central nervous system pathology in pediatric AIDS: An autopsy study. APMIS Suppl 1989;8:40-57.
10. Hurtrel B, Chakrabarti L, Hurtrel M, Annick Maire M, Dormont D, Montagnier L. Early SIV encephalopathy. J Med Primatol 1991;20:159-66.
11. Lackner AA, Smith MO, Munn RJ, et al. Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol 1991; 139:609-21.
12. Sharer LR, Epstein LG, Cho ES, et al. Pathologic features of AIDS encephalopathy in children: Evidence for LAV/HTLV-III infection of brain. Hum Pathol 1986; 17:271-84.
13. Ward JM, O'Leary TJ, Baskin GB, et al. Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. Am J Pathol 1987; 127:199-205.
14. Zink MC, Amedee AM, Mankowski JL, et al. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol 1997; 151:793-803.
15. Anderson MG, Hauer D, Sharma DP, et al. Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology 1993; 195:616-26.
16. Flaherty M, Hauer DA. Mankowski JL, Zink MC, Clements JE. Molecular and biological characterization of a neurovirulent molecular clone of SIV. J Virol 1997;71:5790-8.
17. Mankowski JL, Flaherty MA, Spelman JP, et al. Pathogenesis of SIV encephalitis: Viral determinants of neurovirulence. J Virol 1997;71:6055-60.
18. Roos MTJ, Lange JMA, deGoede REY, et al. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 1992;165:427-32.
19. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-81.
20. Zink MC, Suryanarayana K, Mankowski JL, et al. High viral load in CSF and brain correlates with severity of SIV encephalitis. J Virol 1999;73: 10480-8.
21. Zink MC, Coleman GD, Mankowski JL, et al. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 2001;184:1015-21.
22. Babas T, Munoz D, Mankowski JL, Tarwater PM, Clements JE, Zink MC. Pathogenesis of SIV encephalitis: Selective replication of SIV genotypes in brain and microglial cells. J Virol (in press).
23. An SF, Giometto B, Groves M, et al. Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 1997;56:1262-8.
24. Mankowski JL, Queen SE, Tarwater PM, Fox KJ, Perry VH. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002;61:85-90.
25. Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, Nottet HS. The neuropathogenesis of HIV-1. J Leukoc Biol 1994;56:387-8.
26. Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997;175:963-6.
27. Cinque P, Vago L, Ceresa D, et al. Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis. AIDS 1998;12:389-94.
28. Di Stefano M, Monno L, Fiore JR, et al. Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype. AIDS 1998;12:737-43.
29. Ellis RJ, Ksia K, Spector SA, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997;42:679-88.
30. McArthur JC, McClernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997;42:689-98.
31. Clements JE, Babas T, Mankowski JL, et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): Steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002;186:905-13.
32. Levy JA. The importance of the innate immune system in controlling HIV infection and disease. Trends Immunol 2001;22:312-6.
33. Bruunsgaard H, Pedersen C, Skinhoj P, Pedersen BK. Clinical progression of HIV infection: Role of NK cells. Scand J Immunol 1997;46:91-5.
34. Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P, Pedersen BK. Defective natural immunity: An early manifestation of human immunodeficiency virus infection. J Exp Med 1995;182:789-99.
35. Shieh TM, Carter DL, Blosser RL, Mankowski JL, Zink MC, Clements JE. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol 2001;7:11-24.
36. Mankowski JL, Carter DL, Spelman JP, et al. Pathogenesis of SIV pneumonia: An immunopathologic response to virus. Am J Pathol 1998;153: 1123-30.
37. Anderson P. TIA-1: Structural and functional studies on a new class of cytolytic effector molecule. Curr Top Microbiol Immunol 1995;198:131-43.
38. Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85: 1135-48.
39. Doranz BJ, Rucker J, Yanjie Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusin cofactors. Cell 1996;85:1149-58.
40. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
41. Edinger AL, Amedee A, Miller K, et al. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci USA 1997;94:4005-10.
42. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE. β-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 1998;44:831-5.
43. Kurihara T, Warr G, Loy J, Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997;186:1757-62.
44. McManus CM, Weidenheim K, Woodman SE, et al. Chemokine and chemokine-receptor expression in human glial elements: Induction by the HIV protein, tat, and chemokine autoregulation. Am J Pathol 2000;156: 1441-53.
45. Cinque P, Vago L, Mengozzi M, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998;12:1327-32.
46. Conant K, Garzino-Demo A, Nath A, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998;95:3117-21.
47. Clark SJ, Shaw GM. The acute retroviral syndrome and the pathogenesis of HIV-1 infection. Semin Immunol 1993;5:149-55.
48. Giavedoni LD, Planelles V, Haigwood NL, et al. Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. J Virol 1993;67:577-83.
49. Wesselingh SL, Takahashi K, Glass JD, McArthur JC, Griffin JW, Griffin DE. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol 1997;74:1-8.
50. Persidsky Y, Zheng J, Miller D, Gendelman HE. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 2000;68:413-22.
51. Tomlinson GS, Simmonds P, Busuttil A, Chiswick A, Bell JE. Upregulation of microglia in drug users with and without pre-symptomatic HIV infection. Neuropathol Appl Neurobiol 1999;25:369-79.
52. Ransohoff RM, Hamilton TA, Tani M, et al. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 1993;7:592-600.
53. Berman JW, Guida MP, Warren J, Amat J, Brosnan CF. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol 1996;156:3017-23.
54. Weihe E, Nohr D, Sharer L, Murray E, Rausch D, Eiden L. Cortical astrocytosis in juvenile rhesus monkeys infected with simian immunodeficiency virus. Neuroreport 1993;4:263-6.
55. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999;13:1-22.